Martin O. Andersen
Plus aucun poste en cours
Historique de carrière de Martin O. Andersen
Anciens postes connus de Martin O. Andersen
Sociétés | Poste | Début | Fin |
---|---|---|---|
Scandinavian Life Science Invest ApS
Scandinavian Life Science Invest ApS Investment ManagersFinance Scandinavian Life Science Invest ApS (Scandinavian Life Science Invest) is a venture capital firm with offices in Copenhagen and Stockholm. They were founded in 2000. Scandinavian Life Science Invest was created following the merger of the life science team from The Sixth Swedish National Pension Fund, Medicon Valley Capital and Innoventus. Their investor base comprises Scandinavian pension funds, financial institutions, life science firms, and banks. | Private Equity Investor | 01/05/2003 | 31/12/2013 |
Millimed A/S
Millimed A/S Medical/Nursing ServicesHealth Services Millimed A/S develops treatment solutions for vascular disease. The company also develops next generation alternatives for site specific drug and agent elution. It provides electro-spinning programs to support regeneration of vessels in diseased and abnormal vasculature. Millimed was founded in May 2004 and is headquartered in Roskilde, Denmark | Président | - | 25/06/2009 |
Symphogen A/S
Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Directeur/Membre du Conseil | - | 01/02/2009 |
Cellectricon AB
Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Cellectricon AB provides cell-based screening services to accelerate drug discovery. The firm develops and validates exciting central nervous system and peripheral pain assays using primary cells, accelerating the path from assay validation to compound screening. Its system is equipped with an imaging-based microplate reader to simultaneously record transient fluorescence and luminescence signals, providing real-time monitoring and readouts of cell culture response. The company was founded by Jan Owe Owesson Orwar, Daniel T. Chiu and Stig Anders Jakob Lindberg in 1999 and is headquartered in Molndal, Sweden. | Directeur/Membre du Conseil | 29/10/2009 | - |
PricewaterhouseCoopers, Inc.
PricewaterhouseCoopers, Inc. Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers, Inc. is a South African company that provides accounting, auditing, and bookkeeping services. The company is based in Sunninghill, South Africa. | Corporate Officer/Principal | - | - |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Directeur Financier/CFO | - | - |
Sophion Bioscience A/S
Sophion Bioscience A/S Medical SpecialtiesHealth Technology Sophion Bioscience A/S develops, manufactures and markets instruments and supplies automated patch clamping. It develops throughput patch clamp solutions for functional characterization of living cells. The firm products are used in pharmaceutical and biotech companies around the world. The company was founded in July 2007 and is headquartered in Ballerup, Denmark. | Directeur/Membre du Conseil | - | - |
NOVO NORDISK A/S | Directeur Financier/CFO | - | - |
Gyros AB
Gyros AB Medical SpecialtiesHealth Technology Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden. | Directeur/Membre du Conseil | - | - |
░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Formation de Martin O. Andersen
Scandinavian International Management Institute | Masters Business Admin |
Statistiques
Internationale
Danemark | 8 |
Suède | 3 |
Etats-Unis | 2 |
Opérationnelle
Director/Board Member | 5 |
Director of Finance/CFO | 2 |
Private Equity Investor | 1 |
Sectorielle
Health Technology | 6 |
Commercial Services | 3 |
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
NOVO NORDISK A/S | Health Technology |
Entreprise privées | 9 |
---|---|
Scandinavian Life Science Invest ApS
Scandinavian Life Science Invest ApS Investment ManagersFinance Scandinavian Life Science Invest ApS (Scandinavian Life Science Invest) is a venture capital firm with offices in Copenhagen and Stockholm. They were founded in 2000. Scandinavian Life Science Invest was created following the merger of the life science team from The Sixth Swedish National Pension Fund, Medicon Valley Capital and Innoventus. Their investor base comprises Scandinavian pension funds, financial institutions, life science firms, and banks. | Finance |
PreciSense A/S
PreciSense A/S Electronic Equipment/InstrumentsElectronic Technology PreciSense A/S developed and distributed non-invasive blood glucose monitoring systems that allows for frequent and painless measurement of blood glucose for the long term benefit of diabetics. Its products were used to control day-to-day therapy both regarding insulin administration in Type I and other therapies in Type II diabetes in order to prevent late stage complications. PreciSense was founded in 1995 and was headquartered in Horsholm, Denmark. | Electronic Technology |
Gyros AB
Gyros AB Medical SpecialtiesHealth Technology Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden. | Health Technology |
Sophion Bioscience A/S
Sophion Bioscience A/S Medical SpecialtiesHealth Technology Sophion Bioscience A/S develops, manufactures and markets instruments and supplies automated patch clamping. It develops throughput patch clamp solutions for functional characterization of living cells. The firm products are used in pharmaceutical and biotech companies around the world. The company was founded in July 2007 and is headquartered in Ballerup, Denmark. | Health Technology |
Symphogen A/S
Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Health Technology |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
PricewaterhouseCoopers, Inc.
PricewaterhouseCoopers, Inc. Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers, Inc. is a South African company that provides accounting, auditing, and bookkeeping services. The company is based in Sunninghill, South Africa. | Commercial Services |
Millimed A/S
Millimed A/S Medical/Nursing ServicesHealth Services Millimed A/S develops treatment solutions for vascular disease. The company also develops next generation alternatives for site specific drug and agent elution. It provides electro-spinning programs to support regeneration of vessels in diseased and abnormal vasculature. Millimed was founded in May 2004 and is headquartered in Roskilde, Denmark | Health Services |
Cellectricon AB
Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Cellectricon AB provides cell-based screening services to accelerate drug discovery. The firm develops and validates exciting central nervous system and peripheral pain assays using primary cells, accelerating the path from assay validation to compound screening. Its system is equipped with an imaging-based microplate reader to simultaneously record transient fluorescence and luminescence signals, providing real-time monitoring and readouts of cell culture response. The company was founded by Jan Owe Owesson Orwar, Daniel T. Chiu and Stig Anders Jakob Lindberg in 1999 and is headquartered in Molndal, Sweden. | Commercial Services |
- Bourse
- Insiders
- Martin O. Andersen
- Expérience